94 related articles for article (PubMed ID: 15080972)
1. The design, preparation and SAR of novel small molecule sodium (Na(+)) channel blockers.
Ashwell MA; Lapierre JM; Kaplan A; Li J; Marr C; Yuan J
Bioorg Med Chem Lett; 2004 May; 14(9):2025-30. PubMed ID: 15080972
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects].
Li W; Zhou Y; Liu HM; You QD
Yao Xue Xue Bao; 2009 Feb; 44(2):101-8. PubMed ID: 19408676
[TBL] [Abstract][Full Text] [Related]
3. 2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2.
Rivara M; Baheti AR; Fantini M; Cocconcelli G; Ghiron C; Kalmar CL; Singh N; Merrick EC; Patel MK; Zuliani V
Bioorg Med Chem Lett; 2008 Oct; 18(20):5460-2. PubMed ID: 18818069
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
[TBL] [Abstract][Full Text] [Related]
5. 2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships.
Fantini M; Rivara M; Zuliani V; Kalmar CL; Vacondio F; Silva C; Baheti AR; Singh N; Merrick EC; Katari RS; Cocconcelli G; Ghiron C; Patel MK
Bioorg Med Chem; 2009 May; 17(10):3642-8. PubMed ID: 19394229
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
[TBL] [Abstract][Full Text] [Related]
7. 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Liberatore AM; Schulz J; Pommier J; Barthelemy MA; Huchet M; Chabrier PE; Bigg D
Bioorg Med Chem Lett; 2004 Jul; 14(13):3521-3. PubMed ID: 15177465
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis.
Hirsh AJ; Molino BF; Zhang J; Astakhova N; Geiss WB; Sargent BJ; Swenson BD; Usyatinsky A; Wyle MJ; Boucher RC; Smith RT; Zamurs A; Johnson MR
J Med Chem; 2006 Jul; 49(14):4098-115. PubMed ID: 16821771
[TBL] [Abstract][Full Text] [Related]
9. Phenyl isoxazole voltage-gated sodium channel blockers: structure and activity relationship.
Macsari I; Sandberg L; Besidski Y; Gravenfors Y; Ginman T; Bylund J; Bueters T; Eriksson AB; Lund PE; Venyike E; Arvidsson PI
Bioorg Med Chem Lett; 2011 Jul; 21(13):3871-6. PubMed ID: 21641215
[TBL] [Abstract][Full Text] [Related]
10. Constrained analogues of tocainide as potent skeletal muscle sodium channel blockers towards the development of antimyotonic agents.
Catalano A; Carocci A; Corbo F; Franchini C; Muraglia M; Scilimati A; De Bellis M; De Luca A; Camerino DC; Sinicropi MS; Tortorella V
Eur J Med Chem; 2008 Nov; 43(11):2535-40. PubMed ID: 18342401
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel class of isoxazoline voltage gated sodium channel blockers.
Shao PP; Ye F; Weber AE; Li X; Lyons KA; Parsons WH; Garcia ML; Priest BT; Smith MM; Felix JP; Williams BS; Kaczorowski GJ; McGowan E; Abbadie C; Martin WJ; McMasters DR; Gao YD
Bioorg Med Chem Lett; 2009 Sep; 19(18):5329-33. PubMed ID: 19674896
[TBL] [Abstract][Full Text] [Related]
12. 3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.
Yang J; Gharagozloo P; Yao J; Ilyin VI; Carter RB; Nguyen P; Robledo S; Woodward RM; Hogenkamp DJ
J Med Chem; 2004 Mar; 47(6):1547-52. PubMed ID: 14998340
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines.
Hunt T; Atherton-Watson HC; Axford J; Collingwood SP; Coote KJ; Cox B; Czarnecki S; Danahay H; Devereux N; Howsham C; Hunt P; Paddock V; Paisley D; Young A
Bioorg Med Chem Lett; 2012 Jan; 22(2):929-32. PubMed ID: 22197144
[TBL] [Abstract][Full Text] [Related]
14. Phenethyl nicotinamides, a novel class of Na(V)1.7 channel blockers: structure and activity relationship.
Kers I; Macsari I; Csjernyik G; Nylöf M; Skogholm K; Sandberg L; Minidis A; Bueters T; Malmborg J; Eriksson AB; Lund PE; Venyike E; Luo L; Nyström JE; Besidski Y
Bioorg Med Chem Lett; 2012 Oct; 22(19):6108-15. PubMed ID: 22939696
[TBL] [Abstract][Full Text] [Related]
15. Imidazopyridines: a novel class of hNav1.7 channel blockers.
London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
[TBL] [Abstract][Full Text] [Related]
16. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
[TBL] [Abstract][Full Text] [Related]
17. Stereospecific synthesis of "para-hydroxymexiletine" and sodium channel blocking activity evaluation.
Catalano A; Carocci A; Fracchiolla G; Franchini C; Lentini G; Tortorella V; De Luca A; De Bellis M; Desaphy JF; Conte Camerino D
Chirality; 2004 Feb; 16(2):72-8. PubMed ID: 14712469
[TBL] [Abstract][Full Text] [Related]
18. Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.
Liberatore AM; Schulz J; Favre-Guilmard C; Pommier J; Lannoy J; Pawlowski E; Barthelemy MA; Huchet M; Auguet M; Chabrier PE; Bigg D
Bioorg Med Chem Lett; 2007 Mar; 17(6):1746-9. PubMed ID: 17234409
[TBL] [Abstract][Full Text] [Related]
19. Structural trends among second-generation voltage-gated sodium channel blockers.
Kemp MI
Prog Med Chem; 2010; 49():81-111. PubMed ID: 20855039
[No Abstract] [Full Text] [Related]
20. Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.
Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Sep; 16(18):8607-18. PubMed ID: 18752960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
